SA PRO
Free Account
Calumet, Inc.CLMTNASDAQ
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating
Hold
19 analysts·Moderate coverage
32%
Rating Distribution
Strong Buy
00%
Buy
632%
Hold
1263%
Sell
15%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Jan 30, 2026Goldman Sachs
Calumet price target raised to $24 from $20 at Goldman Sachs
Target:$24.00
+7.2%from $22.39
Oct 22, 2025Goldman Sachs
Calumet price target raised to $20 from $15 at Goldman Sachs
Target:$20.00
+7.1%from $18.67
Aug 12, 2025UBS
Calumet price target raised to $13.25 from $12 at UBS
Target:$13.25
-4.5%from $13.88
Mar 5, 2025Wells Fargo
Calumet price target lowered to $28 from $29 at Wells Fargo
Target:$28.00
+115.7%from $12.98
Dec 14, 2022UBS
UBS Initiates Coverage On Calumet Specialty with Neutral Rating, Announces Price Target of $15.7
Target:$15.70
+16.5%from $13.48
Apr 21, 2022Wells Fargo
Wells Fargo Maintains Overweight on Calumet Specialty, Raises Price Target to $29
Target:$29.00
+103.2%from $14.27

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance